Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Animalcare Group's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.08.
Animalcare Group's long-term debt to total assets ratio
declined
from Dec. 2024 (0.13) to Dec. 2025 (0.08).
It may suggest that Animalcare Group is progressively becoming less dependent on debt to grow their business.
Animalcare Group (STU:WQ7) LT-Debt-to-Total-Asset Explanation
LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.
Animalcare Group LT-Debt-to-Total-Asset Related Terms
Animalcare Group LT-Debt-to-Total-Asset Historical Data
* Premium members only.
The historical data trend for Animalcare Group's LT-Debt-to-Total-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Animalcare Group (STU:WQ7) has a LT-Debt-to-Total-Asset of 0.08 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Animalcare Group and its competitors.
Is Animalcare Group's LT-Debt-to-Total-Asset too high?
Animalcare Group's current LT-Debt-to-Total-Asset is 0.08. Overall, Animalcare Group has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Animalcare Group's LT-Debt-to-Total-Asset compare to ZTS and UTHR?
Animalcare Group's LT-Debt-to-Total-Asset of 0.08 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Animalcare Group and its competitors. Animalcare Group's current LT-Debt-to-Total-Asset is 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Animalcare Group stock overvalued right now?
Based on GuruFocus' analysis, Animalcare Group (STU:WQ7) is currently considered Fairly Valued. The stock's GF Value™ is €2.85, compared to a current price of €3.00 — trading 5.3% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.08. Animalcare Group's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Animalcare Group (STU:WQ7), the current LT-Debt-to-Total-Asset is 0.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Animalcare Group (STU:WQ7) Overvalued in 2026?
Based on GuruFocus' analysis, Animalcare Group stock appears to be overvalued.
The current stock price of €3.00 is trading 5.3% above its estimated GF Value™ of €2.85.
GuruFocus considers Animalcare Group to be Fairly Valued.
Key valuation signals for STU:WQ7:
LT-Debt-to-Total-Asset: 0.08
GF Value™: €2.85 vs. price of €3.00 (5.3% above fair value)
No single metric tells the full story. See the STU:WQ7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. The company operates in Animalcare Europe and Randlab segment. The company derives maximum revenue from the Animalcare Europe segment engaged in development and sale of veterinary pharmaceutical products in Europe and the European International Partners network. Geographically, the company derives maximum revenue from Europe region, followed by Asia-Pacific and other regions.
77GF Score
Get the complete analysis for STU:WQ7
LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:WQ7 has been successfully added to your 
